JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY) ›› 2016, Vol. 30 ›› Issue (2): 102-105.doi: 10.6040/j.issn.1673-3770.0.2015.391

Previous Articles     Next Articles

Advances on genetic polymorphism of DNA double-strand break repair genes and thyroid carcinoma.

LI Yingying1,2, SONG Xicheng   

  1. 1. Binzhou Medical University, Yantai 264000, Shandong, China;2. Department of Otolaryngology &Head and Neck Surgery, Yantai Yuhuangding Hospital, Medical College of Qingdao University, Yantai 264000, Shandong, China
  • Received:2015-09-17 Online:2016-04-16 Published:2016-04-16

PDF (PC)

1086

Abstract: Failure to repair DNA damage timely and effectively can lead to genome instability, which is directly related to the occurrence of tumor. DNA double-strand break(DSB)is the predominant cause of gene mutation and chromosome fragmentation. It affects the tumor susceptibility and process of carcinogenesis. The DSB repair depends mainly on homologous recombination(HR)and non-homologous end-joining(NHEJ). This paper aims to investigate the correlation between the DSB repair gene polymorphism and thyroid carcinoma susceptibility.

Key words: DNA double-strand break, Recombination repair, Thyroid carcinoma

CLC Number: 

  • R736.1
[1] Siraj A K, Hussain A R, Al-Rasheed M, et al. Demethylation of TMS1 gene sensitizes thyroid cancer cells to TRAIL-induced apoptosis[J]. J Clin Endocrinol Metab, 2011, 96(1):E215-224.
[2] Schneider D F, Chen H. New developments in the diagnosis and treatment of thyroid cancer[J]. CA Cancer J Clin, 2013, 63(6):373-394.
[3] Hundahl S A, Fleming I D, Fremgen A M, et al. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995[J]. Cancer, 1998, 8(12):2638-2648.
[4] 钱碧云, 陈可欣, 何敏, 等. 天津市区甲状腺癌流行状况调查[J]. 中国肿瘤临床, 2005, 3294):218-221.
[5] Knauf J A, Ward L S, Nikiforov Y E, et al. Isozyme-specific abnormalities of PKC in thyroid cancer: evidence for post-transcriptional changes in PKC epsilon[J]. J Clin Endocrinol Metab, 2002, 87(5):2150-2159.
[6] Hartlerode A J, Scully R. Mechanisms of double-strand break repair in somatic mammalian cells[J]. Biochem J, 2009, 423(2):157-168.
[7] Symington L S, Gautier J. Double-strand break end resection and repair pathway choice[J]. Annu Rev Genet, 2011, 45:247-271.
[8] Shrivastav M, De Haro L P, Nickoloff J A. Regulation of DNA double-strand break repair pathway choice[J]. Cell Res, 2008, 18(1):134-147.
[9] Lieber M R, Ma Y, Pannicke U, et al. Mechanism and regulation of human non-homologous DNA end-joining[J]. Nat Rev Mol Cell Biol, 2003, 4(9):712-720.
[10] Zhang H, Hasty P, Bradley A. Targeting frequency for deletion vectors in embryonic stem cells[J]. Mol Cell Biol, 1994, 14(4):2404-2410.
[11] Burma S, Chen B P, Chen D J. Role of non-homologous end joining(NHEJ)in maintaining genomic integrity[J]. DNA Repair(Amst), 2006, 5(9-10):1042-1048.
[12] Summers K C, Shen F, Sierra Potchanant E A, et al. Phosphorylation: the molecular switch of double-strand break repair[J]. Int J Proteomics, 2011, 2011(2011):373816.
[13] Tolle R. Information technology tools for efficient SNP studies[J]. Am J Pharmacogenomics, 2001, 1(4):303-314.
[14] Sehl M E, Langer L R, Papp J C, et al. Associations between single nucleotide polymorphisms in double-stranded DNA repair pathway genes and familial breast cancer[J]. Clin Cancer Res, 2009, 15(6):2192-2203.
[15] Walsh T, King M C. Ten genes for inherited breast cancer[J]. Cancer Cell, 2007, 11(2):103-105.
[16] Fornage M, Doris P A. Single-nucleotide polymorphism genotyping for disease association studies[J]. Methods Mol Med, 2005, 108:159-172.
[17] Bastos H N, Ant(~overa)o M R, Silva S N, et al. Association of polymorphisms in genes of the homologous recombination DNA repair pathway and thyroid cancer risk[J]. Thyroid, 2009, 19(10):1067-1075.
[18] Gomes B C, Silva S N, Azevedo A P, et al. The role of common variants of non-homologous end-joining repair genes XRCC4, LIG4 and Ku80 in thyroid cancer risk[J]. Oncol Rep, 2010, 24(4):1079-1085.
[19] Kuschel B, Auranen A, McBride S, et al. Variants in DNA double-strand break repair genes and breast cancer susceptibility[J]. HumMol Genet, 2002, 11(12):1399-1407.
[20] Figueroa J D, Malats N, Rothman N, et al. Evaluation of genetic variation in the double-strand break repair pathway and bladder cancer risk[J]. Carcinogenesis, 2007, 28(8):1788-1793.
[21] Roddam P L, Rollinson S, ODriscoll M, et al. Genetic variants of NHEJ DNA ligase IV can affect the risk of developing multiple myeloma, a tumour characterized by aberrant class switch recombination[J]. J Med Genet, 2002, 39(12):900-905.
[22] Liu Y, Zhang H, Zhou K, et al. Tagging SNPs in nonhomologous end-joining pathway genes and risk of glioma[J]. Carcinogenesis, 2007, 28(9):1906-1913.
[23] Hayden P J, Tewari P, Morris D W, et al. Variation in DNA repair genes XRCC3, XRCC4, XRCC5 and susceptibility to myeloma[J]. Hum Mol Genet, 2007, 16(24):3117-3127.
[24] Tseng R C, Hsieh F J, Shih C M, et al. Lung cancer susceptibility and prognosis associated with polymorphisms in the non-homologous end-joining pathway genes: a multiple genotype-phenotype study[J]. Cancer, 2009, 115(13):2939-2948.
[25] Sturgis E M, Zhao C, Zheng R, et al. Radiation response genotype and risk of differentiated thyroid cancer: a case-control analysis[J]. Laryngoseope, 2005, 115(6):938-945.
[26] Yuan K, Huo M, Sun Y, et al. Association between x-ray repair cross-complementing group 3(XRCC3)genetic polymorphisms and papillary thyroid cancer susceptibility in a Chinese Han population[J]. Tumour Biol, 2015, DOI:10.1007/s13277-015-3882-4.
[27] Shen M R, Jones I M, Mohrenweiser H. Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans[J]. Cancer Res, 1998, 58(4):604-608.
[28] Bao Y, Jiang L, Zhou J Y, et al. XRCC1 Gene Polymorphisms and the Risk of Differentiated Thyroid Carcinoma(DTC): A Meta-Analysis of Case-Control Studies[J]. PLoSOne, 2013, 8(5):e64851.
[29] Ryu R A, Tae K, Min H J, et al. XRCC1 polymorphisms and risk of papillary thyroid carcinoma in a Korean sample[J]. J Korean Med Sci, 2011, 26(8):991-995.
[30] Chiang F Y, Wu C W, Hsiao P J, et al. Association between polymorphisms in DNA base excision repair genes XRCC1, APE1, and ADPRT and differentiated thyroid carcinoma[J]. Clin Cancer Res, 2008, 14(18):5919-5924.
[31] Zhu Q X, Bian J C, Shen Q, et al. Genetic polymorphisms in X-ray repair cross-complementing gene 1 and susceptibility to papillary thyroid carcinoma[J]. Chin J Epidemiology, 2004, 25(8):702-705.
[32] Rahimi M, Fayaz S, Fard-Esfahani A, et al. The role of Ile3434Thr XRCC7 gene polymorphism in Differentiated Thyroid Cancer risk in an Iranian population[J]. Iran Biomed J, 2012, 16(4):218-222.
[1] ZHANG Zhonghua, WANG Hui, WANG Junxin, ZHANG Meiling, ZHANG Jian, ZHANG Endong, PAN Xinliang. Comparison of safety and efficacy between transaxillary endoscopic thyroidectomy and conventional open thyroidectomy for Stage T1 thyroid carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 161-167.
[2] XIAO Fuliang, LIN Yun, PAN Xinliang. A clinical study on prophylactic central lymph node dissection in early cN0 papillary thyroid carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(1): 64-71.
[3] WANG Anyang, LI Chaoyou, XUE Gang, WU Jingfang. Relationship between intestinal flora and thyroid diseases [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(1): 132-139.
[4] LI Jingjing, WU Xinxin, MAO Ning, ZHENG Guibin, MU Yakui, CHU Tongpeng, JIA Chuanliang, ZHENG Haitao, MI Jia, SONG Xicheng. CT-based radiomics nomogram for the preoperative prediction of central lymph node metastases of papillary thyroid carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2021, 35(4): 51-59.
[5] XUE Gang, SUN Xinmin, LIN Xu, WU Jingfang. Expression and clinical significance of the KCNK5 double-pore potassium channel protein in papillary thyroid carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2021, 35(4): 64-69.
[6] ZENG Bo, TIAN Xingde. Relationship between serum procalcitonin level of tumor-bearing mice and medullary thyroid carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2021, 35(1): 86-91.
[7] QING Xiaoyan,XU Yiquan,LI Chao. Advances in molecular mechanisms of anaplastic thyroid cancer [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(3): 26-31.
[8] DENG Di, LIU Jun, LI Linke, WANG Ji, LIU Jifeng, LV Dan, WANG Haiyang, GAN Weigang, WANG Jun, LI Bo, CHEN Fei. Two-stage reconstructive strategy using a flap for non-circumferential tracheal defects [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(3): 52-57.
[9] FANG Zhongju, ZHANG Yongxia, ZHAO Jiandong, ZONG Liang, ZHAI Xingyou, LI Xinjian, PENG Xin, REN Nan, CHEN Liwei, LIU Mingbo. Combined treatment of chylous leakage after lymph node dissection for thyroid cancer [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(3): 64-68.
[10] HUANG Naisi, MA Ben, GUAN Qing, WANG Yunjun, WEI Wenjun, LU Zhongwu, YANG Shuwen, XU Weibo, XIANG Jun, JI Qinghai, WANG Yu. Lateral neck lymph node mapping in thyroid cancer surgery [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(3): 69-74.
[11] Jingrong, CHEN Chun, MA Yan, XIE Jin. Clinical characteristics and risk factors for differentiated thyroid carcinoma in children [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(3): 88-94.
[12] MA Chi, ZHENG Guibin, SUN Haiqing, WU Guochang, GUO Yawen, KONG Yang, SONG Xicheng, ZHENG Haitao. Enhanced recovery after surgery applied to 100 cases of thyroid cancer surgery [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(3): 107-110.
[13] XU Shuhang, LI Chunrui, LIU Chao. Optimal management of differentiated thyroid carcinoma in children. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(6): 12-15.
[14] SUN Bin, GUO Bomin, KANG Jie, DENG Xianzhao, WU Bo, FAN Youben. Standardization of the diagnosis and treatment of anaplastic thyroid carcinoma. [J]. J Otolaryngol Ophthalmol Shandong Univ, 2017, 31(6): 16-20.
[15] SUN Guochen, SUN Yan, ZHANG Hong, WANG Baowei. Clinical characteristics and treatment of differentiated thyroid carcinoma in children. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(6): 25-28.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Website Copyright: Editorial Office of Journal of Otolaryngology and Ophthalmology of Shandong University
Address: No.27 Shanda South Road, Jinan, Shandong, China. Post code: 250100 Tel: +86-0531-88366912 Email: ebhxb@sdu.edu.cn Supported by Beijing Magtech Co.Ltd